Johann Choux, Head of Proparco’s Investments, Financial Institutions and Innovation Division, sets out the major issues tackled in this edition of the magazine.Continue Reading
Along with Asia and Latin America, Africa is currently one of the regions most affected by the trade in counterfeit drugs which account for almost one-third of pharmaceutical products on sale in these regions. The Continue Reading
Pharmivoire Nouvelle is a pioneering manufacturer of medical intravenous solutions in Côte d’Ivoire. Its 25 years’ experience are proof that locally-based production of pharma products is a realistic, sustainable Continue Reading
Pharmaceutical production grew globally over the last decades: active ingredients and finished products are manufactured across different regions, and circulate through multiple distribution channels. Sadly, Continue Reading
“Public health” oriented licenses and patent pooling in Africa promotes research and production of affordable, high quality generic treatments for AIDS, hepatitis C and tuberculosis. The United Nations Continue Reading
The market for medicine is one of the world’s most closely regulated: each country has its own system for vetting new products and in Europe for example, certain accreditations can open the door to the entire EU Continue Reading
From Warehouse to Patient: mPharma’s Approach to increasing the Accessibility of Medicines in Africa
Since 2013, the start-up mPharma has been trying to build an infrastructure and a drug monitoring system to connect patients, hospitals and pharmacies. The objective is to enable doctors to know the exact location Continue Reading
In Sub-Saharan Africa, integrated technology-enabled distribution networks can increase access, enhance quality and lower the prices of medicines. Sub-Saharan Africa’s pharmaceutical market represents a huge Continue Reading
With 13% of the world’s population and 24% of the global burden of disease – but 6% of health expenditure and only 3% of the world’s pharmaceutical output, Africa faces the challenge of access to quality medicines. Continue Reading
Access to proper medicine is a major challenge for African countries. While the global market is mature and highly profitable, the African Continent has been left far behind despite enormous needs and huge growth Continue Reading
